Medical Excellence Capital, LLC
MEC is an early-stage life sciences venture fund deploying precision capital to advance precision health innovations.
In the firm's own words, from its website.
9 additional team members, 2 verified contacts (1 general firm email, 1 firm phone)
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Nothing material in the last 180 days.
People to know
View all people- Managing PartnerWhy: Managing partner: runs the firmNo route on file yet
- Managing PartnerWhy: Managing partner: runs the firmNo route on file yet
- Managing PartnerWhy: Managing partner: runs the firmNo route on file yet
Relationship network
16 connected entities
From financing rounds and every investor named in them, Form ADV and Form D filings, the firm's funds and team, and disclosed LP commitments in the venture capital graph. A round's amount is the size of the round, not money that moved between two investors.
Some relationships on this record are counted rather than named here. They open with the full profile.
Click any name or line for the rounds and sources behind it. Line weight is rounds together; dashed lines are inferred.
- Sponsor
- Company
- Fund or vehicle
- Person
›How strength and recency are read
Co-investors are read from the rounds: three or more shared rounds is a strong observed relationship, two a repeat co-investor, one a single round. Funds and people are structural. Nothing is scored that a reader cannot check.
Darker lines were active in the last 24 months or are current; lighter lines are older or undated.
How am I connected?
Name your firm, a company or a person, and DFX finds the published routes to Medical Excellence Capital, LLC: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.
See how you connect to Medical Excellence Capital, LLC
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Investing
2 companies on record, 0 new in 12 months
Investments on record
What these amounts mean“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.Acquired, Public, Exited and Active are what the firm’s own portfolio card says, read on the date shown when you hover the chip; they are not deal dates. A company with no chip is one whose card states no outcome: DFX does not assume it is active.| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| SYN001 – Arctic Therapeutics | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Firm website |
| Trotana Therapeutics | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Firm website |
Stated thesis versus observed behaviour
- Sectors
- ai, biotech, space
- Stages
- seed, series a, series b, early
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Team
13 current, 0 departed
Decision makers
- Eric Heil · Managing PartnerWhy this person: Managing partner: runs the firm; Named with investment responsibility
- Joni Mancini · Managing PartnerWhy this person: Managing partner: runs the firm; Named with investment responsibility
- Kim Kamdar · Managing PartnerWhy this person: Managing partner: runs the firm; Named with investment responsibility
Ranked by the role the firm or its filing states, a route on file and deals led. Every reason is read from the record, never inferred. Routes are published by the person or the firm (their bio, the team page or a filing) and are revealed on a plan; data bought from a provider is never shown, and a route printed at a firm the person has since left is held back.
Investment team
How the team is orderedPartners who lead rounds first (rounds led, then deals attributed, then seniority), then the rest of the investment team, then investor relations, finance and operations. A person named by two sources under two spellings is shown once.- Managing Partner
- Managing Partner
- Managing Partner
Contacts
1 general firm email, 1 firm phone on record, each with its source. Values open with the complete profile.
Funds and LPs
1 vehicle, 0 LPs disclosed
Funds and vehicles
What these amounts meanGAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Medical Excellence Capital Partners, LP | Fund | unknown | Unknown | $146M Mar 6, 2026 | 11 | unknown | unknown |
Limited partners
Known LPs and allocators
What these amounts and dates areEach commitment is counted once across the pension tape and the allocator graph. A commitment date prints only when the source printed one; otherwise the row carries the report date. A foundation’s 990-PF line is a holding at fair value, never a commitment. Rows without a fund on the venture graph are commitments to this manager.Relationships across DFX
1 co-investors
Co-investors
- 2026-09-301 shared deal · one time
Evidence and history
2 dated events, 58 observations from 4 sources
Timeline
- Dec 23, 2021Medical Excellence Capital, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)
- Dec 23, 2021Medical Excellence Capital Partners, LP first reported on Form ADV by Medical Excellence Capital, LLC (Venture Capital Fund), GAV $104,300,000
Identity and regulatory footprint
Address, phone, Form ADV filing and ownersForm ADV filed Mar 6, 2026 · 1 private fundsShowHide
- Headquarters
- unknown
- Office address
- unknown
- Business phone
- unknownadviserinfo.sec.gov
- Website
- medexcelcap.com
- SEC adviser type
- Exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- Venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 6, 2026
- Private funds reported
- 1 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets, adviser total
- $146Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- ICT Holdings Ltd. (Member Of Medical Excellence Capital Llc And Medical Excellence Gp Llc), owns 5% to 10%; Siracusa, LLC (Managing Member Of Medical Excellence Capital Llc And Medical Excellence Gp Llc), owns 75% or more
Classification history
Classification history
Every classification this record has carried1 on recordShowHide
- Sep 12, 2026Institutional venture firm (confirmed, 95%)Venture manager, reported GAV $146M across 1 vehicle
Evidence
Every observation behind this profile, with its source, date and class
| Fact | Value | Effective | Class | Source |
|---|---|---|---|---|
| Why admitted | VC exemption, VC funds reported | Mar 6, 2026 | Fact | Form ADV |
| SEC exemption claimed | Venture capital fund adviser | Mar 6, 2026 | Fact | Form ADV |
| SEC exemption claimed | Venture capital fund adviser | Dec 16, 2024 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 6, 2026 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 6, 2026 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Dec 16, 2024 | Fact | Form ADV |
| First Form ADV filing | 2021-12-23 | Mar 6, 2026 | Fact | Form ADV |
| First Form ADV filing | 2021-12-23 | Dec 16, 2024 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-30 | Oct 1, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-29 | Sep 30, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-25 | Sep 26, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-23 | Sep 24, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-21 | Sep 23, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-22 | Sep 23, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1 | Sep 12, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2026-03-06 | Mar 6, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2026-03-06 | Mar 6, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2024-12-16 | Dec 16, 2024 | Fact | Form ADV |
| SEC status | ERA - Active | Mar 6, 2026 | Fact | Form ADV |
| SEC status effective | 2021-12-23 | Mar 6, 2026 | Fact | Form ADV |
| Venture share of reported funds | 1 | Mar 6, 2026 | Fact | Form ADV |
| Venture share of reported funds | 1 | Dec 16, 2024 | Fact | Form ADV |
| Business phone | Mar 6, 2026 | Fact | Form ADV | |
| Business phone | Dec 16, 2024 | Fact | Form ADV | |
| Contact page url | Sep 16, 2026 | Fact | ||
| Description | Sep 16, 2026 | Fact | ||
| Description | Sep 15, 2026 | Fact | ||
| Self-described type | Venture capital “A PURPOSE-BUILT VENTURE FIRM” | Sep 16, 2026 | Fact | |
| Self-described type | Venture capital “A PURPOSE-BUILT VENTURE FIRM” | Sep 15, 2026 | Fact | |
| Legal form | Limited Liability Company | Mar 6, 2026 | Fact | Form ADV |
| Legal form | Limited Liability Company | Dec 16, 2024 | Fact | Form ADV |
| Portfolio page | Sep 16, 2026 | Fact | ||
| Portfolio page | Sep 15, 2026 | Fact | ||
| Private funds reported | 1 | Mar 6, 2026 | Fact | Form ADV |
| Private funds reported | 1 | Mar 6, 2026 | Fact | Form ADV |
| Private funds reported | 1 | Dec 16, 2024 | Fact | Form ADV |
| Private fund gross assets (reported) | $146M | Mar 6, 2026 | Fact | Form ADV |
| Private fund gross assets (reported) | $146M | Mar 6, 2026 | Fact | Form ADV |
| Private fund gross assets (reported) | $146M | Dec 16, 2024 | Fact | Form ADV |
| Schedule a diff | sadiff-1 | Mar 6, 2026 | Fact | Form ADV |
| Stated sectors | AI, biotech, space “sector words on the home page” | Sep 16, 2026 | Fact | |
| Stated sectors | AI, biotech, space “sector words on the home page” | Sep 15, 2026 | Fact | |
| Stated stages | Seed, series a, series b, early “stage words on the home page” | Sep 16, 2026 | Fact | |
| Stated stages | Seed, series a, series b, early “stage words on the home page” | Sep 15, 2026 | Fact | |
| Team page | Sep 16, 2026 | Fact | ||
| Team page | Sep 15, 2026 | Fact | ||
| Venture funds reported | 1 | Mar 6, 2026 | Fact | Form ADV |
| Venture funds reported | 1 | Mar 6, 2026 | Fact | Form ADV |
| Venture funds reported | 1 | Dec 16, 2024 | Fact | Form ADV |
| Website | Dec 16, 2024 | Fact | Form ADV | |
| Site title | Sep 16, 2026 | Fact | ||
| Site title | Sep 15, 2026 | Fact |
How this is scored
Scores, classification basis and filing advisersInstitutional venture firm, confirmedShowHide
Venture manager, reported GAV $146M across 1 vehicle
- importance
- gav: 0.35 · funds: 0.08 · people: 0.52 · investments: 0.11 · co investors: 0
- active deployment
- investments 12m: 0 · fund raising 18m: 0 · people joined 12m: 0 · vintage within 3y: 0 · latest investment at: not scored
- emerging manager
- fund count: 1 · reported gav: $146M · first adv filing: 2021-12-23 · years since first filing: 4.8
Fits, record history and connections
scored matches for this investor, every identity change, every edge
Record history
- Adviser's first ADV filing2021-12-23source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.
Not yet on record: latest vintage.